How a protein called prohibitin-1 helps protect the heart during sepsis
Determinants of cardioprotection by circulating prohibitin-1 during sepsis
This study is looking at a protein called prohibitin-1 in the blood to see how it helps protect the heart during sepsis, a serious condition that causes inflammation, and it aims to find new ways to treat and diagnose heart issues related to sepsis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11060899 on NIH RePORTER |
What this research studies
This research investigates the role of prohibitin-1, a protein found in the blood, in protecting the heart during sepsis, a severe inflammatory condition. The study aims to understand how prohibitin-1 influences heart function and metabolism when the body is under stress from sepsis. By examining the mechanisms through which this protein operates, researchers hope to identify new targets for treatment and biomarkers for diagnosis. The approach includes using mouse models to observe the effects of prohibitin-1 on heart health during sepsis.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing sepsis or are at risk of developing septic complications.
Not a fit: Patients who do not have sepsis or related acute inflammatory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve heart function and reduce mortality in patients suffering from sepsis.
How similar studies have performed: Previous research has shown promising results in understanding the role of prohibitin-1 in cellular functions, suggesting potential for success in this novel approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Anderson, Ethan John — University of Iowa
- Study coordinator: Anderson, Ethan John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.